Abstract:

Objective    To study the clinical effect of electric coagulation hemostasis under nasal endoscopy for treatment of intractable nosebleed. Methods    Clinical data of intractable nosebleed patients received treatment at our hospital from 2011 to 2012 were retrospectively analyzed. Patients were divided into two groups. Group A received nasal endoscopic treatment and group B received packing hemostasis treatment. Cure rate, complications, pain scale, recovery and rehaemorrhagia rate were compared between the two groups. Results    Group A had a higher cure rate than group B(97.2%， 69/71 vs 84.0%， 42/50； P=0.0095).The pain scales were lower in group A both peri-treatment and post-treatment than in group B (3.08±0.72 vs 4.72±0.49; P＜0.001; 2.59±0.48 vs 4.21±0.58; P＜0.001). The group A patients had a sooner recovery than group B patients (P＜0.001). Group A patients had a lower rehaemorrhagia rate than group B patients(5.6%， 4/71 vs  46.0%， 23/50； P＜0.001). Conclusion    Electric coagulation hemostasis under nasal endoscopy is a safe and effective treatment for intractable nosebleed.

Key words: Nasal endoscopy, Complications； Pain, Packing hemostasis, Intractable nosebleed